ES2020925B3 - Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas. - Google Patents

Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.

Info

Publication number
ES2020925B3
ES2020925B3 ES86116703T ES86116703T ES2020925B3 ES 2020925 B3 ES2020925 B3 ES 2020925B3 ES 86116703 T ES86116703 T ES 86116703T ES 86116703 T ES86116703 T ES 86116703T ES 2020925 B3 ES2020925 B3 ES 2020925B3
Authority
ES
Spain
Prior art keywords
preparation
aryloxypropanolamines
procedure
same
crystalline salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86116703T
Other languages
English (en)
Inventor
Gerhard Zolss
Gerhard Pfarrhofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rorer International Overseas Inc
Original Assignee
Rorer International Overseas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer International Overseas Inc filed Critical Rorer International Overseas Inc
Application granted granted Critical
Publication of ES2020925B3 publication Critical patent/ES2020925B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
ES86116703T 1985-12-13 1986-12-02 Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas. Expired - Lifetime ES2020925B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853544172 DE3544172A1 (de) 1985-12-13 1985-12-13 Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
ES2020925B3 true ES2020925B3 (es) 1991-10-16

Family

ID=6288400

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86116703T Expired - Lifetime ES2020925B3 (es) 1985-12-13 1986-12-02 Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.

Country Status (13)

Country Link
US (2) US4767784A (es)
EP (1) EP0229947B1 (es)
JP (1) JPS62155238A (es)
AT (1) ATE61573T1 (es)
CS (1) CS259896B2 (es)
DD (1) DD262426A1 (es)
DE (2) DE3544172A1 (es)
DK (1) DK597786A (es)
ES (1) ES2020925B3 (es)
FI (1) FI864970A7 (es)
GR (1) GR3001691T3 (es)
HU (1) HU206669B (es)
NO (1) NO165393C (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
JP2003505485A (ja) * 1999-07-30 2003-02-12 ランバクシー ラボラトリーズ リミテッド フォームiセリプロロールヒドロクロリドの改良形態
MY143244A (en) * 2002-11-26 2011-04-15 Smithkline Beecham Corp Calcilytic compounds
ITMI20040145A1 (it) * 2004-01-30 2004-04-30 Acraf L-moprololo lpiu' tartrato
EP1723107A2 (en) 2004-02-23 2006-11-22 Cadila Healthcare Ltd. Process for manufacture of racemic carvedilol
WO2008002683A2 (en) * 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Polymorphous forms of carvedilol phosphate
GB2442238B (en) * 2006-09-29 2008-10-01 Rolls Royce Plc Sheet metal blank
MX2019011242A (es) 2017-03-23 2020-01-21 Graybug Vision Inc Farmacos y composiciones para el tratamiento de trastornos oculares.
GB2593902B (en) 2020-04-07 2022-04-13 Actimed Therapeutics Ltd Salt of a pharmaceutical compound

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB448181A (en) * 1934-07-12 1936-05-25 Chem Ind Basel Manufacture of basic esters of polyarylacetic acids
US2517856A (en) * 1949-05-12 1950-08-08 Kay Fries Chemicals Inc Method of preparing diphenyl acetic acid
NL301580A (es) * 1962-12-11
NL131194C (es) * 1963-07-19
CA956632A (en) * 1969-05-16 1974-10-22 Yoshitomi Pharmaceutical Industries Phenoxy-aminopropanol derivatives
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
NL7115581A (es) * 1970-11-13 1972-05-16 Dresden Arzneimittel
GB1396322A (en) * 1971-06-15 1975-06-04 Ici Ltd Alkanolamine derivatives
HU167262B (es) * 1972-12-22 1975-09-27
HU170678B (es) * 1973-12-20 1977-08-28
AT335465B (de) * 1974-11-20 1977-03-10 Chemie Linz Ag Verfahren zur herstellung von neuen 3-(p-ureidophenoxy)-2-hydroxy-aminopropanen sowie deren saureadditionssalzen
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
AT335464B (de) * 1974-11-19 1977-03-10 Chemie Linz Ag Verfahren zur herstellung von neuen 3-(p-ureidophenoxy)-2-hydroxy-aminopropanen sowie deren saureadditionssalzen
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
AT350539B (de) * 1976-02-09 1979-06-11 Squibb & Sons Inc Verfahren zur herstellung von neuen 4-(3-subst. amino-2-hydroxpropoxy)-5,6,7,8-tetrahydro- 1,6,7-naphthalintriolen
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
US4294966A (en) * 1978-07-28 1981-10-13 Ciba-Geigy Corporation Process for inverting the configuration in optically active compounds
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
US4404213A (en) * 1981-01-26 1983-09-13 Shell Oil Company Derivatives of certain pyridyliminomethyl-benzenes
DE3309595A1 (de) * 1983-03-17 1984-09-20 Basf Ag, 6700 Ludwigshafen Neue aminopropanolderivate von 1-(2-hydroxy-phenyl)-3-phenyl-propanolen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
JPS62155238A (ja) 1987-07-10
DE3544172A1 (de) 1987-06-19
HUT46292A (en) 1988-10-28
GR3001691T3 (en) 1992-11-23
HU206669B (en) 1992-12-28
ATE61573T1 (de) 1991-03-15
CS884386A2 (en) 1987-11-12
US4849530A (en) 1989-07-18
DD262426A1 (de) 1988-11-30
CS259896B2 (en) 1988-11-15
EP0229947A1 (de) 1987-07-29
DK597786D0 (da) 1986-12-12
NO165393C (no) 1991-02-06
DK597786A (da) 1987-06-14
US4767784A (en) 1988-08-30
DE3678139D1 (de) 1991-04-18
FI864970L (fi) 1987-06-14
EP0229947B1 (de) 1991-03-13
NO864635D0 (no) 1986-11-20
NO165393B (no) 1990-10-29
FI864970A0 (fi) 1986-12-05
NO864635L (no) 1987-06-15
FI864970A7 (fi) 1987-06-14

Similar Documents

Publication Publication Date Title
PT87754A (pt) Process for the preparation of new amino acid derivatives
ES557643A0 (es) Procedimiento para la obtencion de derivados de acidos benzoheterociclilalcanoicos
AR243510A1 (es) Procedimiento para la obtencion de derivados de acidos <541>7-amino-1-ciclopropil-6,8-dihalogeno-1,4 dihidro-4-oxo-3-quinolincarboxilico
FI892603A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 4-(kinolin-2-yylimetoksi)fenyylietikkahappojohdannaisten valmistamiseksi
ES494590A0 (es) Procedimiento para la preparacion de derivados de acidos b- carbolin-3-carboxilicos
ES494989A0 (es) Procedimiento para la preparacion de derivados de aminoaci- dos
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
ES557515A0 (es) Procedimiento para la obtencion de derivados del acido piridin-3-carboxilico
FI871087A7 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
DK330585D0 (da) Kombinationspraeparat af pyrimido-pyrimidiner og 0-acetylsalicylsyre og deres farmaceutisk acceptable salte
DK597786A (da) Krystallinske salte af aryloxypropanolaminer og fremgangsmaade til fremstilling heraf
ES490069A0 (es) Procedimiento para la preparacion de derivados de amidas de acidos 1,2,3-tiadiazol-5-carboxilicos
FI900145L (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
SE8101963L (sv) Monohydrerad isoftalsyrapikolylamid, forfarande for dess framstellning samt farmaceutisk anvendning derav
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI881032A7 (fi) Menetelmä N-asetyyli-3 -fluorineuramiinihappojohdannaisten valmistamiseksi.
ES554304A0 (es) Procedimiento de preparar nuevas sales de acidos carboxilicos, terapeuticamente utiles
ES494594A0 (es) Procedimiento para la preparacion de derivados de acidos al-canocarboxilicos
ES497208A0 (es) Un procedimiento para las preparaciones de nuevos derivados de 1,1'-bifenil-2-il-alquilamina
MX3908E (es) Procedimiento para la purificacion de derivados de acido-4,4'-bis-triazenilamino-estilben-2,2'-disulfonico y las sales del mismo
ES556359A0 (es) Procedimiento para la preparacion de nuevos derivados de la 2-halonicergolina y sus sales acidas complementarias.
ES2063784T3 (es) Procedimiento para la preparacion de derivados de pirrolizina.
ES557626A0 (es) Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos
ES550074A0 (es) Procedimiento para la fabricacion de derivados del acido 4-hidroxi-2-metil-2h-1,2-benzotiazina-1,1-dioxido-3-carboxi-lico
MX8938A (es) Nuevos derivados del acido 1,5-difenilpirazol-3-carboxilico y procedimiento para su preparacion